DE3685937D1 - Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen. - Google Patents

Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.

Info

Publication number
DE3685937D1
DE3685937D1 DE8686902720T DE3685937T DE3685937D1 DE 3685937 D1 DE3685937 D1 DE 3685937D1 DE 8686902720 T DE8686902720 T DE 8686902720T DE 3685937 T DE3685937 T DE 3685937T DE 3685937 D1 DE3685937 D1 DE 3685937D1
Authority
DE
Germany
Prior art keywords
fibrinogen
marked
soluble
bond
test procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686902720T
Other languages
English (en)
Other versions
DE3685937T2 (de
Inventor
George J Doellgast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3685937D1 publication Critical patent/DE3685937D1/de
Application granted granted Critical
Publication of DE3685937T2 publication Critical patent/DE3685937T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/4616—Snake venom from Russell's viper
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447—Factor VII (3.4.21.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE8686902720T 1985-04-22 1986-04-14 Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen. Expired - Fee Related DE3685937T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/725,460 US4668621A (en) 1985-04-22 1985-04-22 Detecting blood clotting factors with immobilized fibrinogen and labeled fibrinogen
PCT/US1986/000769 WO1986006489A1 (en) 1985-04-22 1986-04-14 Assays with surface-bound fibrinogen and soluble, labeled fibrinogen

Publications (2)

Publication Number Publication Date
DE3685937D1 true DE3685937D1 (de) 1992-08-13
DE3685937T2 DE3685937T2 (de) 1993-01-14

Family

ID=24914654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686902720T Expired - Fee Related DE3685937T2 (de) 1985-04-22 1986-04-14 Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.

Country Status (7)

Country Link
US (1) US4668621A (de)
EP (1) EP0221927B1 (de)
JP (1) JP2529677B2 (de)
AT (1) ATE78098T1 (de)
CA (1) CA1270193A (de)
DE (1) DE3685937T2 (de)
WO (1) WO1986006489A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US6541275B1 (en) 1988-02-03 2003-04-01 Dade Behring Inc. Immunoassay for F1.2 prothrombin fragment
WO1989009409A1 (en) * 1988-03-31 1989-10-05 Ram Nunna Immunoassays employing novel markers
US5071745A (en) * 1988-12-14 1991-12-10 Elcatech, Inc. Fibrinolytic assay
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP0477302B1 (de) * 1989-06-15 1995-02-01 SMITH, William I. Jr. Vorrichtung zur inaktivierung infektioeser erreger und zur verhinderung der koagulierung in biologischen flüssigkeiten
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
GB9122180D0 (en) * 1991-10-18 1991-11-27 Marconi Gec Ltd Separation and analysis
AU681074B2 (en) * 1992-03-20 1997-08-21 Millennium Pharmaceuticals, Inc. Glycosylation-mediated inhibition of factor X
US5476771A (en) * 1993-02-22 1995-12-19 The United States Of America As Represented By The Secretary Of The Army Test for quantitative thrombin time
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
US5985548A (en) * 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
EP0685069A4 (de) * 1993-02-17 2002-01-23 Cardiovascular Diagnostics Inc Immunoassay und affinitätstest auf der grundlage einer trockenchemischen kaskade
US5567596A (en) * 1994-12-29 1996-10-22 Research Foundation Of State University Of New York Rapid assay of activators and inhibitors of clotting
US5858665A (en) * 1996-07-25 1999-01-12 Navix, Inc. Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
US5879897A (en) * 1996-09-23 1999-03-09 Wake Forest University Methods and compositions for the diagnosis of extraesophageal gastric reflux
FR2769093B1 (fr) * 1997-09-30 1999-11-12 Pasteur Sanofi Diagnostics Procede in vitro d'evaluation des risques thrombotiques par dosage du fibrinogene plasmatique
DE19756773A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik
US6596501B2 (en) 1998-02-23 2003-07-22 Fred Hutchinson Cancer Research Center Method of diagnosing autoimmune disease
EP2295978A3 (de) 1998-03-20 2012-06-06 The Curators Of The University Of Missouri Verwendung von PAGs (Pregnancy-associated Glycoproteins) zur frühen Diagnostizierung der Schwangerschaft
US6632628B1 (en) 1999-08-20 2003-10-14 Board Of Regents, The University Of Texas System Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
US6511809B2 (en) 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
AU2002330102A1 (en) 2001-09-28 2003-04-14 Aspenbio, Inc. Bovine pregnancy test
NZ572488A (en) * 2002-05-02 2009-10-30 Univ Wyoming Pregnancy detection
US7790410B2 (en) 2008-04-25 2010-09-07 General Electric Company Method and apparatus for determining hemocompatibility
US20110117064A1 (en) * 2009-10-13 2011-05-19 Christof Westenfelder Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
EP2333555A1 (de) 2009-12-09 2011-06-15 Siemens Healthcare Diagnostics Products GmbH Heterogener Gerinnungstest
US8541187B2 (en) 2011-03-01 2013-09-24 Bio Tracking, LLC Systems and methods for detecting animal pregnancy
US9594081B2 (en) 2011-06-20 2017-03-14 Proterixbio, Inc. Methods and systems for the rapid characterization of functional biological molecules
WO2014019644A1 (en) * 2012-07-31 2014-02-06 Baxter International Inc. Selective measurement of active human protease coagulation factors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960669A (en) * 1973-01-15 1976-06-01 Association For Pharmacologic Research, Inc. Urine diagnostic test for fibrinolytic activity
DE2431342C3 (de) * 1973-07-27 1978-10-26 Behringwerke Ag, 3550 Marburg Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe
US3778352A (en) * 1973-02-23 1973-12-11 Baxter Laboratories Inc Plasminogen assay system
US4046635A (en) * 1975-08-27 1977-09-06 Canadian Patents And Development Limited Method for detecting enzymes capable of digesting fibrinogen or fibrin
NL7511055A (nl) * 1975-09-19 1977-03-22 Leuven Res & Dev Vzw Trombosetest.
US4045635A (en) * 1976-01-22 1977-08-30 Robertshaw Controls Company Electrical switch construction and improved overtravel switch blade therefor and method of making the same
US4463090A (en) * 1981-09-30 1984-07-31 Harris Curtis C Cascade amplification enzyme immunoassay
WO1985004426A1 (en) * 1984-03-26 1985-10-10 International Health Services A method of determining the clotting time of blood and particulate reagents therefor

Also Published As

Publication number Publication date
CA1270193A (en) 1990-06-12
EP0221927A4 (de) 1988-06-20
ATE78098T1 (de) 1992-07-15
EP0221927A1 (de) 1987-05-20
JPS62502938A (ja) 1987-11-26
DE3685937T2 (de) 1993-01-14
JP2529677B2 (ja) 1996-08-28
WO1986006489A1 (en) 1986-11-06
EP0221927B1 (de) 1992-07-08
US4668621A (en) 1987-05-26

Similar Documents

Publication Publication Date Title
DE3685937D1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
ATE311601T1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
ES2088992T3 (es) Metodo para determinar los niveles de factores de coagulacion intrinsecos y extrinsecos y proteina c.
EP0384130A3 (de) Herzinfarkt-Immunoassay
DK104093D0 (da) Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
ES2043612T3 (es) Procedimiento para la determinacion fotometrica de la actividad de proteina c y/o proteina s.
ES2098406T3 (es) Ensayo funcional y reactivo para la determinacion de fibrinogeno.
ATE123340T1 (de) Diagnostischer nachweis unter verwendung von chimären antikörpern.
NO178578C (no) Fremgangsmåte for ekstraksjon av tromboplastiner samt anvendelse av det ekstraherte tromboplastin
AU8600082A (en) Radioimmunoassay for fibrinopeptide a using a tripeptide thrombin inhibitor
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
DK603087D0 (da) Immunokemisk metod tilbestemmelse af stabilt glycosyleret haemoglobin
NO821101L (no) Reagens for optisk bestemmelse av blodkoagulasjonsforholdet
ATE114054T1 (de) Fibrinolytischer test.
ATE250084T1 (de) Typ i prokollagen aminoterminales propeptid, dessen antikörper und testverfahren unter verwendung davon
ATE88571T1 (de) Immunologischer testkit.
ATE323286T1 (de) Verfahren zum bestimmen von autoantikörpern
NO175024C (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter, samt prövesett omfattende reagensen
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
AU613083B2 (en) A method for the determination of soluble fibrin
ES2016992B3 (es) Reagente y procedimiento en la determinacion c 3a mediante ensayo inmunoquimico.
DE3485740D1 (de) Immunologisches testverfahren eines prokoagulierenden enzyms zum nachweis von krebs.
Brown Application of Immunologic Assays to the Coagulation Laboratory
ES2085917T3 (es) Ensayos que comprenden inmunoglobulinas mezcladas para la deteccion de factores reumatoides.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee